Related Experiment Video
Updated: Aug 15, 2026

Analytical Techniques for Assaying Nitric Oxide Bioactivity
Published on: June 18, 2012
Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro
G R Upchurch1, J W Ford, S J Weiss
1Jobst Vascular Research Laboratories, Section of Vascular Surgery, Department of Surgery, University of Michigan Medical School, USA. riversu@umich.edu
Objective:
The hypothesis to be tested was that diminished bioavailable nitric oxide (NO) affects matrix metalloproteinase (MMP) expression and activation in vascular smooth muscle cells (SMCs).
Methods:
Cultivated rat aortic SMCs (RA-SMCs) were exposed to increasing concentrations of L-N-monomethyl arginine (L-NMMA), a nonselective inhibitor of NO synthase, in the presence of proinflammatory cytokines (50 ng/mL interleukin [IL]-1beta, 50 ng/mL interferon-gamma, and 30 microg/mL lipopolysaccharide). Nitrite and nitrate, two of the final end products of NO metabolism, were measured in media collected at 48 hours with the use of the Saville assay (n = 4). MMP activity was measured with 1% gelatin zymography (n = 4). In separate experiments in which 2 ng/mL of IL-1beta and L-NMMA was used, MMP protein and messenger RNA (mRNA) levels were determined with Western blot analysis (n = 3) and semiquantitative reverse transcriptase-polymerase chain reaction (n = 3), respectively. Data were analyzed with nonparametric analysis of variance.
Results:
Increasing concentrations of the NO synthase inhibitor L-NMMA caused a dose-dependent decrease (P <.05) in nitrite and nitrate production by RA-SMCs after cytokine exposure. Zymography documented an early dosedependent increase (P <.05 compared with cytokines alone) in 92-kd MMP activity, with no significant changes in 72-kd MMP activity after treatment with L-NMMA (P >.05 compared with cytokines alone). Reverse transcriptase-polymerase chain reaction and Western blot analysis revealed that the addition of L-NMMA to IL-1beta-stimulated RA-SMCs led to significant increases in MMP-9 mRNA (n = 3, P <.01 for 1.0 mmol/L L-NMMA) and MMP-9 protein levels (n = 3, P <.05), respectively. No differences in MMP-2 mRNA or protein levels were demonstrated.
Conclusions:
Inhibition of cytokine-induced NO expression in RA-SMCs is associated with a selective, dose-dependent increase in MMP-9 expression and synthesis. These findings suggest that alterations in local NO synthesis may influence MMP-9-dependent vessel wall damage.
Insights
Diminished nitric oxide (NO) production in vascular smooth muscle cells increases matrix metalloproteinase-9 (MMP-9) expression and activity. This suggests NO plays a role in MMP-9-mediated vessel wall damage.
Area of Science:
- Vascular Biology
- Molecular Biology
- Biochemistry
Background:
- Nitric oxide (NO) is crucial for vascular homeostasis.
- Matrix metalloproteinases (MMPs) are implicated in vascular remodeling and disease.
- The relationship between NO bioavailability and MMP expression in vascular smooth muscle cells (SMCs) requires further elucidation.
Purpose of the Study:
- To investigate the effect of diminished bioavailable nitric oxide (NO) on matrix metalloproteinase (MMP) expression and activation in rat aortic SMCs (RA-SMCs).
Main Methods:
- RA-SMCs were treated with increasing concentrations of L-N-monomethyl arginine (L-NMMA), a NO synthase inhibitor, and proinflammatory cytokines.
- Nitrite/nitrate levels, MMP activity (zymography), MMP-9 mRNA, and MMP-9 protein were quantified.
Main Results:
- L-NMMA treatment dose-dependently decreased nitrite and nitrate production.
- MMP-9 activity, mRNA, and protein levels significantly increased with L-NMMA exposure.
- No significant changes were observed in MMP-2 levels.
Conclusions:
- Inhibition of NO synthesis in RA-SMCs leads to a selective, dose-dependent increase in MMP-9 expression and synthesis.
- These findings indicate that reduced NO bioavailability may contribute to vascular damage via MMP-9 upregulation.
More Related Videos
Related Concept Videos
Nitric Oxide Signaling Pathway
Role of Matrix Metalloproteases in Degradation of ECM
A...

